1. Home
  2. RLYB vs NMTC Comparison

RLYB vs NMTC Comparison

Compare RLYB & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rallybio Corporation

RLYB

Rallybio Corporation

SELL

Current Price

$10.66

Market Cap

28.7M

Sector

Health Care

ML Signal

SELL

Logo NeuroOne Medical Technologies Corporation

NMTC

NeuroOne Medical Technologies Corporation

HOLD

Current Price

$0.82

Market Cap

34.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLYB
NMTC
Founded
2018
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.7M
34.3M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
RLYB
NMTC
Price
$10.66
$0.82
Analyst Decision
Hold
Strong Buy
Analyst Count
2
3
Target Price
N/A
$1.98
AVG Volume (30 Days)
201.4K
205.0K
Earning Date
01-01-0001
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
27.72
80.43
EPS
N/A
N/A
Revenue
$600,000.00
$9,097,692.00
Revenue This Year
$17.61
N/A
Revenue Next Year
N/A
$32.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
163.47
52 Week Low
$0.22
$0.40
52 Week High
$11.20
$1.15

Technical Indicators

Market Signals
Indicator
RLYB
NMTC
Relative Strength Index (RSI) 92.99 56.95
Support Level $0.48 $0.70
Resistance Level N/A $0.86
Average True Range (ATR) 0.76 0.07
MACD 0.55 0.00
Stochastic Oscillator 89.39 81.64

Price Performance

Historical Comparison
RLYB
NMTC

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

About NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

Share on Social Networks: